다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

ARQL

ArQule (ARQL)

ArQule Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ARQL

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2020/02/15	07:35	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ARQL	ArQule Inc
2020/02/15	02:20	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ARQL	ArQule Inc
2020/02/13	07:03	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ARQL	ArQule Inc
2020/02/13	02:05	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ARQL	ArQule Inc
2020/02/11	03:43	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ARQL	ArQule Inc
2020/02/06	01:29	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ARQL	ArQule Inc
2020/01/28	03:55	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:ARQL	ArQule Inc
2020/01/21	20:00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ARQL	ArQule Inc
2020/01/21	20:00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ARQL	ArQule Inc
2020/01/21	20:00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ARQL	ArQule Inc
2020/01/07	01:07	PR Newswire (US)	Moore Kuehn, PLLC Encourages Investors of KEM, ARQL, THOR, and LOGM to Contact the Firm	NASDAQ:ARQL	ArQule Inc
2019/12/13	05:49	PR Newswire (US)	SHAREHOLDER ALERT: WeissLaw LLP Investigates ArQule, Inc.	NASDAQ:ARQL	ArQule Inc
2019/12/10	17:02	Dow Jones News	Merck, Sanofi Push To Add Cancer Drugs -- WSJ	NASDAQ:ARQL	ArQule Inc
2019/12/10	09:16	Dow Jones News	Big Drugmakers Push Deeper Into Cancer Treatment -- 4th Update	NASDAQ:ARQL	ArQule Inc
2019/12/10	06:37	Dow Jones News	Big Drugmakers Push Deeper Into Cancer Treatment -- 3rd Update	NASDAQ:ARQL	ArQule Inc
2019/12/10	05:12	Dow Jones News	U.S. Stocks Slip as Trade War Weighs on Chinese Exports	NASDAQ:ARQL	ArQule Inc
2019/12/10	04:33	Dow Jones News	Big Drugmakers Push Deeper Into Cancer Treatment -- 2nd Update	NASDAQ:ARQL	ArQule Inc
2019/12/10	01:13	Dow Jones News	Merck to Buy ArQule for $2.7 Billion -- Update	NASDAQ:ARQL	ArQule Inc
2019/12/09	22:05	Business Wire	ArQule Announces Final Phase 1 Clinical Data for Its Reversible BTK Inhibitor, ARQ 531, at the American Society of Hematology...	NASDAQ:ARQL	ArQule Inc
2019/12/09	21:37	PR Newswire (US)	(ARQL) Alert: Johnson Fistel Investigates Proposed Sale of ArQule, Inc.; Is $20 a Fair Price?	NASDAQ:ARQL	ArQule Inc
2019/12/09	21:26	Dow Jones News	Merck to Buy ArQule for $2.7 Billion, or $20/Share	NASDAQ:ARQL	ArQule Inc
2019/12/09	20:45	Business Wire	Merck to Acquire ArQule, Advancing Leadership in Oncology	NASDAQ:ARQL	ArQule Inc
2019/11/25	21:00	Business Wire	ArQule to Present Clinical Data for its Reversible BTK Inhibitor, ARQ 531, at the American Society of Hematology 2019 Annual ...	NASDAQ:ARQL	ArQule Inc
2019/11/13	21:00	Business Wire	ArQule to Participate in the Jefferies London Healthcare Conference on November 20, 2019	NASDAQ:ARQL	ArQule Inc
2019/11/06	23:05	Business Wire	ArQule Announces Release of American Society of Hematology Abstract Detailing Results of the Ongoing Phase 1 Study of Reversi...	NASDAQ:ARQL	ArQule Inc
2019/10/30	23:57	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ARQL	ArQule Inc
2019/10/30	20:30	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARQL	ArQule Inc
2019/10/30	20:00	Business Wire	ArQule Reports Third Quarter 2019 Financial Results	NASDAQ:ARQL	ArQule Inc
2019/10/30	05:01	Business Wire	ArQule Presents Recent Data on ARQ 751 at the 2019 AACR-NCI-EORTC International Conference on Molecular Targets & Cancer Ther...	NASDAQ:ARQL	ArQule Inc
2019/10/21	20:00	Business Wire	ArQule Announces Preclinical Data Demonstrating Potential of Miransertib (ARQ 092) to Treat PIK3CA-Driven Vascular Malformati...	NASDAQ:ARQL	ArQule Inc

검색 관련기사 보기:NASDAQ:ARQL

1 2 3 4 5 6 7 8 9 10 다음 >>

Charter Hall Retail REIT

Cury Construtora E Incor... ON

Traka Resources

NLBNPIT22AR1 20240717 16...

MGIC Investment

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관